Multi-target FIT aims to offer inexpensive, high-sensitivity alternative to FIT in colorectal cancer screening March 01, 2024Vol.50 No.09By Matthew Bin Han Ong
Health Equity Large study of U.S. veterans shows that gaining housing is associated with improved cancer outcomes March 01, 2024Vol.50 No.09By Jacquelyn Cobb
Trials & Tribulations Cancer AI systems: We need oncologists to help us build trusted models March 01, 2024Vol.50 No.09By Bernard Chien
Black History MonthFreeIn the Archives Before her legendary career at NIH, Vivian Pinn was the second Black woman to graduate from UVA med schoolAs a student, the first director of the NIH Office of Research on Women’s Health helped desegregate Charlottesville March 01, 2024Vol.50 No.09By Robert A. Winn and Alexandria Carolan
Free An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs February 23, 2024Vol.50 No.08By Alexandria Carolan
First-ever commercial TIL therapy: How NCI, Iovance, and Moffitt achieved FDA approval February 23, 2024Vol.50 No.08By Matthew Bin Han Ong
Conversation with The Cancer Letter Steven Rosenberg, Friedrich Graf Finckenstein: FDA recognition of TIL therapy is the result of 40 years of research February 23, 2024Vol.50 No.08By Matthew Bin Han Ong
Black History MonthFreeIn the Archives Roderic Pettigrew, founding director of NIBIB, reflects on a career as a “physicianeer”— merging medicine with engineering February 23, 2024Vol.50 No.08By Robert A. Winn and Alexandria Carolan
Black History MonthConversation with The Cancer Letter University of Maryland’s Owonikoko: What it means to be a Black director of an NCI-designated cancer center February 16, 2024Vol.50 No.07By Amy Lacey, Otis W. Brawley and Paul Goldberg
Capitol Hill Delay in passing the FY24 budget is “disastrous for our cancer centers” February 16, 2024Vol.50 No.07By Alexandria Carolan
